Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avita Medical, Inc.
Valencia, California, United Statesavitamedical.com ↗
- Ownership
- Public · RCEL
- Development stage
- Other
01
Overview
The company has achieved positive results in multiple clinical trials, including a pivotal trial for vitiligo treatment that met its primary effectiveness endpoint of super-superiority in 2022[6], and a pivotal trial for soft-tissue injuries showing statistically superior donor sparing and comparable healing rates[9].
- Therapeutic areas
- OtherDermatologyInfectious Diseases
- Modalities
- Autologous cellular therapiesRegenerative medicine devices
- Industry
- Therapeutic Medical Devices
02
Partnerships
Stedical Scientific (manufacturing and distribution agreement for PermeaDerm Biosynthetic Wound Matrix, March 2025)
03
Financials
- Market cap
- $389.5M
- Total revenue
- $71.6M
- Enterprise value
- $426.2M
Beyond the preview
Go deeper on Avita Medical, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avita Medical, Inc..